Drugs such as Cobenfy could reshape the antipsychotic market, providing a more nuanced range of patient options.

As interest in psychedelic medicine grows, researchers have synthesized a decade of evidence to understand how ayahuasca ...

Explore ayahuasca's effects on anxiety, memory, and emotional processing, revealing its therapeutic potential for ...

The review synthesizes evidence showing that ayahuasca's effects involve a delicate balance between two serotonin receptor types: 5-HT2A and 5-HT1A. This dual action appears crucial for understanding ...

According to the partners, DSP-0038 combines serotonin 5-HT2A receptor antagonism and 5-HT1A receptor agonism – two well established targets for antipsychotic drugs – in a single small molecule.

SF is a 50-year-old woman, counseled about the therapeutic use of psilocybin by her neurologist, who has participated in ...

The Pacalis team is a blend of industry and academic expertise, led by co-founder and Monash university alumnus Dr David Bibby as Chief Executive Officer, and co-founder Professor Chris Langmead, ...

Axovant turned its attention to another neuroscience drug – 5-HT2A receptor inverse agonist nelotanserin, licensed from Arena Pharma – but that failed a phase 2 study in REM sleep behaviour ...

Live commentary of Melbourne Renegades v Brisbane Heat in the final of the Women's BBL.

Skip More from 5 Live... The 5 Live at 30 Yearbook How 5 Live reported on some of the biggest news and sport stories of the past 30 years. Eleanor Oldroyd: 30 years of "my radio family" Eleanor ...

noradrenergic and specific serotonin receptor antagonists, dopamine and norepinephrine reuptake inhibitors, along with newly introduced antidepressants (e.g., vilazodone and agomelatine).